cytidine has been researched along with Hepatitis B Virus Infection in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Browning, JL; Cheng, X; Chou, WM; Dandri, M; Dejardin, E; Durantel, D; Heikenwalder, M; Heim, MH; Hüser, N; Koppensteiner, H; Liang, TJ; Lucifora, J; Makowska, Z; Münk, C; Protzer, U; Reisinger, F; Remouchamps, C; Schindler, M; Sprinzl, MF; Stadler, D; Thasler, WE; Volz, T; Xia, Y; Zhang, K | 1 |
| Chang, J; Kang, J; Niu, P; Peng, Y; Qiao, Y; Wan, N; Wang, Q; Wang, SQ; Wang, XJ; Wu, J; Yang, Q; Yu, W; Zheng, L | 1 |
| Allweiss, L; Bierwolf, J; Dandri, M; Lütgehetmann, M; Matthes, E; Petersen, J; Pollok, JM; Volz, T; Warlich, M | 1 |
| Chang, J; Fang, X; Wang, Q; Yang, Q; Yang, X; Zang, L; Zhao, J; Zhao, X; Zheng, L | 1 |
| Chen, SH | 1 |
| Kissling, M; Speck, B | 1 |
1 review(s) available for cytidine and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Comparative evaluation of L-Fd4C and related nucleoside analogs as promising antiviral agents.
Topics: Antiviral Agents; Cytidine; Hepatitis B; HIV Infections; Humans; Nucleosides | 2002 |
5 other study(ies) available for cytidine and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.
Topics: Animals; Antibodies, Monoclonal; Antiviral Agents; Cell Line; Cell Nucleus; Cytidine; Cytidine Deaminase; DNA, Circular; DNA, Viral; Hepatitis B; Hepatitis B virus; Hepatocytes; Humans; Interferon-alpha; Liver; Lymphotoxin beta Receptor; Mice, SCID; Minor Histocompatibility Antigens; Proteins; Up-Regulation | 2014 |
Synthesis and biological evaluation of 4-substituted fluoronucleoside analogs for the treatment of hepatitis B virus infection.
Topics: Animals; Antiviral Agents; Cell Line, Tumor; Cytidine; DNA Replication; DNA, Viral; Ducks; Hepatitis B; Hepatitis B virus; Humans; Leukocyte Count; Mice; Models, Molecular; Mutagenicity Tests; Nucleosides; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Toxicity Tests, Acute | 2015 |
Strong antiviral activity of the new l-hydroxycytidine derivative, l-Hyd4FC, in HBV-infected human chimeric uPA/SCID mice.
Topics: Animals; Antiviral Agents; Chimera; Cytidine; DNA, Viral; Hepatitis B; Humans; Lamivudine; Mice; Mice, SCID; Molecular Structure; Urokinase-Type Plasminogen Activator; Viremia; Zalcitabine | 2012 |
Anti-hepatitis B virus activities of α-DDB-FNC, a novel nucleoside-biphenyldicarboxylate compound in cells and ducks, and its anti-immunological liver injury effect in mice.
Topics: Animals; Antiviral Agents; Benzodioxoles; Cell Survival; Chemical and Drug Induced Liver Injury; Concanavalin A; Cytidine; Cytoprotection; DNA Replication; DNA, Viral; Dose-Response Relationship, Drug; Ducks; Hep G2 Cells; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Liver; Male; Mice; Time Factors; Virus Replication | 2012 |
Lymphocyte transforming activity in the serum of patients with hepatic disease.
Topics: Autoradiography; Cholestasis; Culture Techniques; Cytidine; DNA Replication; Globulins; Hepatitis; Hepatitis A; Hepatitis B; Hepatitis B Antigens; Hepatomegaly; Humans; Immune Sera; Liver Diseases; Lymphocyte Activation; Prednisone; RNA; Splenomegaly; Staining and Labeling; Thymidine; Tritium | 1971 |